Fig. 7From: Understanding the implication of Kawakita model parameters using in-die force-displacement curve analysis for compacted and non-compacted API powdersThe compression pressure-relative volume reduction relationship according to Eq. 2 applied to all non-compacted (BC) and compacted (AC) drugs comprising mebeverine, secnidazole, and ciprofloxacinBack to article page